Wayne Edward Hanson, Writer

“Electroceuticals” – Resistance is Futile
Last year, the Wall Street Journal heralded the arrival of “electroceuticals” a portmanteau of “electronics” and “pharmaceuticals” coined by big pharma’s GlaxoSmithKline. Electroceuticals would implant electronic devices about the size of a grain of rice into the brain to “modulate neural signals” directly. While electronic pacemakers, defibrillators and cochlear implants have helped with bodily problems, billions are now being bet on electronic brain implants as a replacement for the heavy hand of psychopharmaceuticals with their no-better-than-placebo results, skyrocketing costs, unpredictable and often lethal side effects, and competition by generic drug equivalents. But nothing about electroceuticals is new except the name. Back in the 1950s, as part of the CIA’s secret MKULTRA mind control program, Jose Manuel Rodriguez Delgado developed devices designed to control human beings remotely. He delivered electrical charges directly to the brains of mental patients with his “stimoceiver” and drugs with his “chemitrode.” In some cases, the signals proved stronger than the subject’s own willpower.

Everybody Must Get Stoned
Now that 26 states and the District of Columbia have some form of legalized marijuana, the psychiatric establishment has discovered that use of the substance can lead to mood swings, paranoia, psychosis, and addiction.  To treat these symptoms, antipsychotics such as Olanzapine and Haloperidol are recommended. Olanzapine is also used for schizophrenia, and side effects include: confusion, coma, mental changes, uncontrolled muscle movements, trouble talking, aggression, dizziness, high blood pressure, and seizures.” Haloperidol has side effects including hallucinations; mental or mood changes, abnormal thinking, anxiety, depression, involuntary grimacing, sucking, and smacking of lips, etc.